Schultheis, B., Folprecht, G., Kuhlmann, J., Ehrenberg, R., Hacker, U. T., Köhne, C. H., . . . Mross, K. B. (2013). Regorafenib in combination with FOLFOX or FOLFIRI as first- or second-line treatment of colorectal cancer: Results of a multicenter, phase Ib study. Oxford University Press.
Chicago ZitierstilSchultheis, B., et al. Regorafenib in Combination With FOLFOX or FOLFIRI As First- or Second-line Treatment of Colorectal Cancer: Results of a Multicenter, Phase Ib Study. Oxford University Press, 2013.
MLA ZitierstilSchultheis, B., et al. Regorafenib in Combination With FOLFOX or FOLFIRI As First- or Second-line Treatment of Colorectal Cancer: Results of a Multicenter, Phase Ib Study. Oxford University Press, 2013.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.